Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 13101-13150 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT04312113
Angiographic Delivery of AD-MSC for Ulcerative Colitis
PHASE1
Active, not recruiting
20 participants
Started: Nov 16, 2020 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04658199
A Study to Test the Safety and Tolerability of Long-term UCB0107 Administration in Study Participants With Progressive Supranuclear Palsy
PHASE1
Active, not recruiting
19 participants
Started: Nov 16, 2020 · Completed: Dec 13, 2027
1 condition
1 sponsor
11 locations
NCT04228107
Treatment Phenotypes for Adolescents With Asthma
NA
Active, not recruiting
120 participants
Started: Nov 16, 2020 · Completed: May 31, 2026
2 conditions
1 sponsor
1 location
NCT04613557
Safety, Activity and Cell Kinetics of CYAD-211 in Patients With Relapsed or Refractory Multiple Myeloma
PHASE1
Active, not recruiting
18 participants
Started: Nov 16, 2020 · Completed: Feb 28, 2037
1 condition
1 sponsor
5 locations
NCT04557176
TB Screening Improves Preventive Therapy Uptake
NA
Active, not recruiting
1,719 participants
Started: Nov 16, 2020 · Completed: Sep 30, 2025
4 conditions
5 sponsors
1 location
NCT04611997
IGG Using in Laparoscopic Gastrectomy for Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy
PHASE3
Active, not recruiting
240 participants
Started: Nov 16, 2020 · Completed: Oct 1, 2026
2 conditions
1 sponsor
1 location
NCT03641313
Berzosertib and Irinotecan in Treating Patients With Progressive, Metastatic, or Unresectable TP53 Mutant Gastric or Gastroesophageal Junction Cancer
PHASE2
Active, not recruiting
17 participants
Started: Nov 16, 2020 · Completed: Jan 28, 2026
8 conditions
1 sponsor
31 locations
NCT04677400
More Than Body Appearance (MBA) Intervention
NA
Active, not recruiting
100 participants
Started: Nov 16, 2020 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04533451
Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer
PHASE2
Active, not recruiting
101 participants
Started: Nov 16, 2020 · Completed: May 31, 2027
7 conditions
2 sponsors
505 locations
NCT04496063
USTekinumab in Fistulising Perianal Crohn's Disease (USTAP)
PHASE4
Active, not recruiting
33 participants
Started: Nov 16, 2020 · Completed: Dec 30, 2025
1 condition
2 sponsors
20 locations
NCT04568824
Neurocognitive Factors in EdTech Intervention Response
NA
Active, not recruiting
450 participants
Started: Nov 15, 2020 · Completed: Aug 1, 2026
1 condition
5 sponsors
1 location
NCT04457674
Targeting Sleep Homeostasis to Improve Alcohol Use Disorder Treatment Outcomes (M-STAR Study)
NA
Active, not recruiting
131 participants
Started: Nov 15, 2020 · Completed: Feb 28, 2026
2 conditions
2 sponsors
1 location
NCT04467957
Non-contrast Lung Perfusion Mapping Applied for New Insights in Cystic Fibrosis
PHASE4
Active, not recruiting
26 participants
Started: Nov 15, 2020 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT04622046
A Phase 3 Study of ALXN2060 in Japanese Participants With Symptomatic ATTR-CM
PHASE3
Active, not recruiting
25 participants
Started: Nov 13, 2020 · Completed: Sep 23, 2025
1 condition
2 sponsors
11 locations
NCT04375826
Preperitoneal Analgesia Versus Epidural Analgesia After Open Pancreaticoduodenectomy
NA
Active, not recruiting
146 participants
Started: Nov 13, 2020 · Completed: Dec 31, 2024
2 conditions
1 sponsor
1 location
NCT04103879
US Study of UM171-Expanded CB in Patients With High Risk Leukemia/Myelodysplasia
PHASE2
Active, not recruiting
30 participants
Started: Nov 13, 2020 · Completed: Feb 28, 2026
2 conditions
2 sponsors
3 locations
NCT04543539
IN.PACT™ AV Access Post-Approval Study (PAS002)
N/A
Active, not recruiting
240 participants
Started: Nov 13, 2020 · Completed: Feb 28, 2029
4 conditions
1 sponsor
20 locations
NCT04577833
A Study of Comparative Formulations of Niraparib and Abiraterone Acetate (AA) in Men With Prostate Cancer
PHASE1
Active, not recruiting
136 participants
Started: Nov 13, 2020 · Completed: Dec 31, 2026
1 condition
1 sponsor
16 locations
NCT05819333
Augmenting a Post-Stroke Wellness Program With Respiratory Muscle Training
NA
Active, not recruiting
80 participants
Started: Nov 13, 2020 · Completed: Apr 30, 2026
1 condition
1 sponsor
1 location
NCT04559945
The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System
NA
Active, not recruiting
326 participants
Started: Nov 13, 2020 · Completed: Aug 31, 2023
2 conditions
1 sponsor
53 locations
NCT04644068
Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies
PHASE1/PHASE2
Active, not recruiting
702 participants
Started: Nov 12, 2020 · Completed: Jun 1, 2027
13 conditions
1 sponsor
68 locations
NCT04598919
Saracatinib in the Treatment of Idiopathic Pulmonary Fibrosis
PHASE1/PHASE2
Active, not recruiting
49 participants
Started: Nov 12, 2020 · Completed: Jun 30, 2025
1 condition
7 sponsors
4 locations
NCT06665542
A Multicenter Prospective Observational Study to Derive and Verify the Performance of a Host-response Based Diagnostic Tool for Early Detection of Severe Infections.
N/A
Active, not recruiting
2,000 participants
Started: Nov 12, 2020 · Completed: Dec 31, 2025
2 conditions
1 sponsor
8 locations
NCT04565821
Feasibility Study to Assess a Trans-nasal Intestinal Potential Difference Probe
NA
Active, not recruiting
15 participants
Started: Nov 12, 2020 · Completed: Apr 30, 2028
5 conditions
1 sponsor
1 location
NCT04567784
Neuroimaging and CBD for Opioid Use Disorder
PHASE2
Active, not recruiting
160 participants
Started: Nov 12, 2020 · Completed: Nov 12, 2025
4 conditions
2 sponsors
1 location
NCT04600583
A Trial of Mechanical Axis With Soft Tissue Release Balancing vs Functional Alignment With Bony Release Balancing in Total Knee Replacement Using Stryker's Mako Robot
NA
Active, not recruiting
278 participants
Started: Nov 12, 2020 · Completed: Mar 31, 2025
1 condition
1 sponsor
1 location
NCT04565769
Cognitive Function in Melanoma Patients Treated With Adjuvant Immune Checkpoint Inhibitors
N/A
Active, not recruiting
100 participants
Started: Nov 12, 2020 · Completed: Mar 31, 2025
9 conditions
2 sponsors
1 location
NCT04557059
A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Hormone-Sensitive Prostate Cancer
PHASE3
Active, not recruiting
694 participants
Started: Nov 12, 2020 · Completed: Aug 27, 2029
1 condition
1 sponsor
141 locations
NCT04569032
A Study of Brentuximab Vedotin and CHP in Frontline Treatment of PTCL With Less Than 10% CD30 Expression
PHASE2
Active, not recruiting
82 participants
Started: Nov 12, 2020 · Completed: Dec 31, 2025
1 condition
1 sponsor
69 locations
NCT05060341
Long-Term Follow-Up Study of AAV2hAQP1 for Radiation Induced Xerostomia
N/A
Active, not recruiting
22 participants
Started: Nov 12, 2020 · Completed: Mar 31, 2027
1 condition
1 sponsor
4 locations
NCT04547686
Efficacy of a Smoke-Free Homes Intervention
NA
Active, not recruiting
918 participants
Started: Nov 11, 2020 · Completed: Aug 31, 2025
1 condition
3 sponsors
1 location
NCT04339101
Itacitinib, Tacrolimus, and Sirolimus for the Prevention of GVHD in Patients With Acute Leukemia, Myelodysplastic Syndrome, or Myelofibrosis Undergoing Reduced Intensity Conditioning Donor Stem Cell Transplantation
PHASE2
Active, not recruiting
59 participants
Started: Nov 11, 2020 · Completed: Jan 20, 2026
5 conditions
2 sponsors
1 location
NCT04482595
BIO 300 Oral Suspension in Previously Hospitalized Long COVID Patients
PHASE2
Active, not recruiting
50 participants
Started: Nov 11, 2020 · Completed: Apr 30, 2025
4 conditions
3 sponsors
4 locations
NCT04207086
A Phase II Study of Neoadjuvant Pembrolizumab & Lenvatinib for Resectable Stage III Melanoma
PHASE2
Active, not recruiting
21 participants
Started: Nov 11, 2020 · Completed: Jan 1, 2033
1 condition
2 sponsors
1 location
NCT04560894
SCT-I10A Plus SCT510 Versus Sorafenib as First-Line Therapy for Advanced Hepatocellular Carcinoma
PHASE2/PHASE3
Active, not recruiting
405 participants
Started: Nov 11, 2020 · Completed: Sep 30, 2024
1 condition
1 sponsor
1 location
NCT04564222
Sustainable Intervention of Supplementation to Improve Kid's Growth Study
NA
Active, not recruiting
324 participants
Started: Nov 11, 2020 · Completed: Dec 31, 2024
4 conditions
6 sponsors
1 location
NCT04230304
Daratumumab and Ibrutinib for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia, DIRECT Study
PHASE2
Active, not recruiting
8 participants
Started: Nov 11, 2020 · Completed: Oct 10, 2027
5 conditions
1 sponsor
1 location
NCT04557150
A Study Evaluating the Safety and Pharmacokinetics of Escalating Doses of Forimtamig in Participants With Relapsed or Refractory Multiple Myeloma (r/r MM)
PHASE1
Active, not recruiting
225 participants
Started: Nov 11, 2020 · Completed: Feb 20, 2026
1 condition
1 sponsor
20 locations
NCT04000906
PIPAC With Nab-paclitaxel and Cisplatin in Peritoneal Carcinomatosis
PHASE1
Active, not recruiting
18 participants
Started: Nov 11, 2020 · Completed: Dec 31, 2024
1 condition
1 sponsor
2 locations
NCT03929029
Neoantigen Vaccine Plus Locally Administered Ipilimumab and Systemic Nivolumab in Advanced Melanoma
PHASE1
Active, not recruiting
11 participants
Started: Nov 11, 2020 · Completed: Sep 30, 2028
1 condition
2 sponsors
1 location
NCT04454658
Safety and Tolerability Study of Oral ABBV-744 Tablet Alone or in Combination With Oral Ruxolitinib Tablet or Oral Navitoclax Tablet in Adult Participants With Myelofibrosis
PHASE1
Active, not recruiting
21 participants
Started: Nov 11, 2020 · Completed: Jan 31, 2027
1 condition
1 sponsor
43 locations
NCT04552223
Nivolumab Plus Relatlimab in Patients With Metastatic Uveal Melanoma
PHASE2
Active, not recruiting
27 participants
Started: Nov 10, 2020 · Completed: Jan 4, 2026
1 condition
3 sponsors
1 location
NCT04624256
Germline DNA-Based Radiosensitivity Biomarker Influence on Toxicity Following Prostate Radiotherapy, GARUDA Trial
NA
Active, not recruiting
226 participants
Started: Nov 10, 2020 · Completed: Dec 31, 2028
6 conditions
2 sponsors
1 location
NCT04593615
Indocyanine Green Tracer Using in Laparoscopic Radical Gastrectomy for Locally Advanced Gastric Cancer
NA
Active, not recruiting
1,070 participants
Started: Nov 10, 2020 · Completed: Aug 17, 2028
2 conditions
1 sponsor
1 location
NCT04281017
Effect of Position and Anesthetic Choice in Intraocular Pressure in Robotic GYN (Gynecologic) Oncology Patients
PHASE4
Active, not recruiting
31 participants
Started: Nov 10, 2020 · Completed: Nov 1, 2025
2 conditions
1 sponsor
1 location
NCT04111172
A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma
PHASE2
Active, not recruiting
48 participants
Started: Nov 10, 2020 · Completed: Mar 1, 2027
38 conditions
1 sponsor
1 location
NCT04606381
A Study of Amivantamab Subcutaneous (SC) Administration for the Treatment of Advanced Solid Malignancies
PHASE1
Active, not recruiting
192 participants
Started: Nov 10, 2020 · Completed: Dec 31, 2026
1 condition
1 sponsor
12 locations
NCT04606472
A Study of SI-B003, a PD-1/CTLA-4 Bispecific Antibody, in Patients With Advanced Solid Tumors
PHASE1
Active, not recruiting
60 participants
Started: Nov 10, 2020 · Completed: Dec 31, 2025
1 condition
2 sponsors
8 locations
NCT04417595
Omega-3 Fatty Acids for Smoking Cessation in Pregnancy
PHASE2
Active, not recruiting
400 participants
Started: Nov 10, 2020 · Completed: Oct 28, 2025
2 conditions
2 sponsors
1 location
NCT04262180
Physical Activity Promotion for Breast and Endometrial Cancer Survivors
NA
Active, not recruiting
323 participants
Started: Nov 9, 2020 · Completed: Jan 31, 2026
3 conditions
3 sponsors
2 locations
Previous
1
More pages
260
261
262
263
264
265
266
More pages
431
Next